Month: October 2018

Khiron Announces Launch of Clinics With the Signing of Agreement to Acquire ILANS

TORONTO, Oct. 24, 2018 /CNW/ – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), an integrated medical cannabis company with its core operations in Colombia, has signed the definitive agreement for the acquisition of the Latin American Institute of Neurology and the Nervous System (“ILANS”) previously announced on August 7, 2018. ILANS is one of the most respected, fastest growing, and largest neurological clinics in Colombia, and becomes a cornerstone of the Khiron Clinics business unit in Latin America.

Canada House Wellness Group Will Hold Annual General Meeting on October 30th

TORONTO, Oct. 23, 2018 (GLOBE NEWSWIRE) — Canada House Wellness Group Inc (“Canada House” or the “Company”) (CSE: CHV) would like to remind its shareholders of its Annual General and Special Meeting of Shareholders (the “Meeting”) which will be held on Tuesday October 30, 2018 at THE ROYAL CANADIAN MILITARY INSTITUTE, The Otter Room (4th Floor), 426 University Avenue, Toronto, Ontario M5G 1S9 at 2:00pm (Eastern Time), for the following purposes:

High Hampton Enters into Binding Letter of Intent to Acquire Licensed California Cannabis Manufacturing Company

TORONTO, Oct. 23, 2018 /CNW/ – High Hampton Holdings Corp. (CSE: HC) (FSE: 0HCN) (“High Hampton” or the “Company”) today announced that it has entered into a binding Letter of Intent (the “LOI”) with Mojave Jane, LLC (“Mojave Jane”) to acquire 100% of all of the issued and outstanding member interests of Mojave Jane (the “Acquisition”).

NuRAN Receives Initial Purchase Order from Africa Mobile Network

Quebec, Canada / TheNewswire / October 23, 2018 – NuRAN Wireless Inc. (“NuRAN Wireless” or the “Company”) (CSE: NUR) (OTC: NRRWF) (FSE: 1RN), announces that it has received an initial purchase order from from Africa Mobile Networks (“AMN”). Nuran’s selection by AMN was initially announced  on June 14, 2018. This purchase order is the first of many expected from AMN.

FSD Pharma Signs Binding LOI to Acquire Therapix Biosciences

TORONTO, Oct. 22, 2018 /CNW/ – FSD Pharma Inc. (“FSD Pharma” or the “Company”) (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) announced today the signing of a binding letter of intent (the “LOI”) to acquire Therapix Biosciences Ltd. (“Therapix Biosciences” or “Therapix”) (NASDAQ: TRPX) effective October 22, 2018. The Transaction (the “Transaction”) combines two highly-complementary businesses and creates a medical cannabis industry innovator focused on the research and development of advanced cannabinoid treatments.

FSD Pharma Director Anthony Durkacz on the Midas Letter

CTV News at FSD Pharma’s Coburg Facility

Vanadium One Energy Appoints Martin Walter as CEO & Director

TORONTO, ON / ACCESSWIRE / October 15, 2018 / Vanadium One Energy Corp. (the “Company”) (TSXV:VONE, FRANKFURT:9VR1), is pleased to announce that is has appointed Martin Walter CEO and Director of the Company, effective immediately. In addition to this change, the Company’s out-going CEO, Mr. John Priestner, has been appointed as COO. Further to this, the Company has hired Mr. Ashley Martin as Vice President – Technical Services. These management changes reflect the Company’s next stage of growth as it furthers the development of its core asset, the Mont Sorcier Iron-Magnetite-Vanadium Project, located 18 kilometres from Chibougamau, Quebec, Canada.

Engagement Labs Finds Consumers Living in a “Political Brand Bubble”

NEW YORK, Oct. 11, 2018 /PRNewswire/ — Today’s polarized political environment is increasingly impacting brand marketers, as dramatically illustrated by Nike’s decision to launch a controversial campaign featuring ex-NFL player Colin Kaepernick. So far, the ad campaign has led to higher sales and company stock price, despite many pundits’ predictions of a negative backlash. It appears Nike’s deep understanding of its target market was a key factor in the initial success of the campaign, as its share of positive word of mouth grew.

NuRAN Introduces Mobile Network Enabler Model

NuRAN Wireless Inc. (CSE:NUR,FWB:1RN,OTCMKTS:NRRWF) (“NuRAN Wireless” or the “Company”), a leading supplier of mobile and broadband wireless infrastructure solutions announces the introduction of its Mobile Network Enabler (“MNE”) business model. The new model will facilitate network rollouts for mobile network operators by providing them with a zero-CAPEX model where NuRAN provides its mobile network solutions as a service.